Breast Cancer | Specialty

The OncLive Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Dr. Ellis on Measuring Endocrine Therapy Efficacy

September 6th 2011

Dr. Matthew J. Ellis from Washington University on Measuring Endocrine Therapy Efficacy With Ki67

Conference Corner: 2 Upcoming Physicians' Education Resource Conferences

August 31st 2011

The 2 upcoming conferences include the 7th Annual Multidisciplinary Symposium on Head and Neck Cancer and the School of Breast Oncology.

Dr. Ellis on Ki67 as Treatment Monitoring Biomarkers

August 31st 2011

Dr. Matthew J. Ellis from Washington University Discusses Ki67 as a Treatment Monitoring Biomarker

Dr. O'Shaughnessy on Breast Cancer Biomarkers

August 30th 2011

Dr. Joyce A. O'Shaughnessy from Baylor Sammons Cancer Center on the Future of Breast Cancer Biomarkers

10 Tips for Breast Cancer Screening and Early Detection

August 29th 2011

Early detection offers the best chance for a cure.

Dr. Ellis Discusses the Future of the PI3-Kinase Pathway

August 26th 2011

Dr. Matthew J. Ellis from Washington University Discusses the Future of the PI3-Kinase Pathway

ASCO 2011: What Nurses Need to Know

August 26th 2011

Personal perspectives from oncology nurses of abstracts presented at ASCO on research with the potential to change practice, important studies that failed to meet expectations, and topics particularly relevant to oncology nurses.

Flaxseed Ineffective in Controlling Hot Flashes

August 25th 2011

Flaxseed had no effect on reducing hot flashes in postmenopausal women who reported experiencing 28 or more hot flashes per week.

Dr. Tripathy on Determining the Best HER2 Targeted Therapy

August 25th 2011

Dr. Debu Tripathy from USC Norris Cancer Center on Determining the Best HER2 Targeted Therapy

Dr. Ellis Discusses the Cell-Proliferation Marker Ki67

August 24th 2011

Dr. Matthew Ellis from Washington University Discusses the Cell-Proliferation Marker Ki67

Racing Against Breast Cancer: A Conversation With Edith A. Perez, MD

August 24th 2011

It's hard to tell which moves more quickly: Edith Perez's feet, or her mind.

ASCO Highlights: Trials in Progress

August 23rd 2011

The following is a roundup of TPS abstracts that feature trials open to patients aged >17 years with a broad range of cancer types.

Dr. O'Shaughnessy on Negative TNBC Iniparib Results

August 23rd 2011

Dr. Joyce O'Shaughnessy from Baylor Sammons Cancer Center on Negative TNBC Iniparib Trial Results

Metformin May Decrease Diabetics' Breast Cancer Risk

August 22nd 2011

In postmenopausal diabetic women, metformin use was associated with lower ER and PR breast cancer incidence.

Dr. Tripathy Discusses HER2 Targeted Therapies

August 22nd 2011

Dr. Debu Tripathy from UC Norris Cancer Center Discusses HER2 Targeted Therapies

Yoga Benefits Patients With Breast Cancer

August 19th 2011

Patients with breast cancer who undertook yoga following radiotherapy derived physical and emotional benefi ts from the ancient Indian practice, according to research presented at ASCO.

Dr. Hendrix on Metastatic Cells in Microenvironments

August 18th 2011

Dr. Mary J. C. Hendrix from Northwestern University's Feinberg School of Medicine on Metastatic Tumor Cells in Microenvironments

Dr. Tripathy on Completing New Assays After Recurrence

August 18th 2011

Dr. Debu Tripathy from USC Norris Cancer Center on Completing New Assays After Recurrence

Breast Cancer Survivors Vulnerable to Long-Term Work Loss

August 17th 2011

Breast cancer survivors who stop working during chemotherapy may face the loss of long-term employment for several years after their diagnosis.

Dr. O'Shaughnessy on Avastin as Her Standard of Care

August 17th 2011

Dr. Joyce A. O'Shaughnessy from Baylor Sammons Cancer Center on Avastin as Her Standard of Care